Management of adult attention deficit hyperactivity disorder in UK primary care: A survey of general practitioners

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  McCarthy, Suzanne ^a,b   Wilton, Lynda ^c   Murray, Macey ^c   Hodgkins, Paul ^d   Asherson, Philip ^e   Wong, Ian C K ^c,f  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d SHIRE   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adult; Attention deficit hyperactivity disorder; General practitioner; Primary care; Stimulant

Indexed keywords

ATOMOXETINE; DEXAMPHETAMINE; METHYLPHENIDATE;

ADULT; ADULT DISEASE; ADULTHOOD; ARTICLE; ATTENTION DEFICIT DISORDER; CHILDHOOD; COHORT ANALYSIS; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; ONSET AGE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DATA COLLECTION; DEXTROAMPHETAMINE; GENERAL PRACTITIONERS; GREAT BRITAIN; HUMANS; MALE; MEDICATION ADHERENCE; METHYLPHENIDATE; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PROPYLAMINES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84874059427     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-22     Document Type: Article

References (33)

1. Clarke S, Heussler H, Kohn MR. Attention deficit disorder: not just for children. Intern Med J 2005, 35(12):721-725.
2. Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 1996, 153(9):1143-1146.
3. Attention deficit hyperactivity disorder: pharmacological and psychological interventions in children, young people and adults http://www.nice.org.uk/CG72.
4. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006, 36(2):159-165.
5. Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugue M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken K, Fitzgerald M. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010, 10:67.
6. McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 2009, 194(3):273-277.
7. Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health Technol Assess 2009, 13(50):iii-iv, ix-xi-1-120.
8. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000, 48(1):9-20.
9. Skirrow C, McLoughlin G, Kuntsi J, Asherson P. Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. Expert Rev Neurother 2009, 9(4):489-503.
10. Rosler M, Casas M, Konofal E, Buitelaar J. Attention deficit hyperactivity disorder in adults. World J Biol Psychiatry 2010, 11(5):684-698.
11. Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother 2005, 5(4):525-539.
12. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007, 190:402-409.
13. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009, 194(3):204-211.
14. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Technology Appraisal 98 http://www.nice.org.uk/TA98.
15. Mental health of children and young people in Great Britain 2004, http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/DH_4118332.
16. McBride D, Hardoon S, Walters K, Gilmour S, Raine R. Explaining variation in referral from primary to secondary care: cohort study. BMJ 2010, 341:c6267.
17. Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD. Cancer incidence in The Health Improvement Network. Pharmacoepidemiol Drug Saf 2009, 18(8):730-736.
18. Lo Re V, Haynes K, Forde KA, Localio AR, Schinnar R, Lewis JD. Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Pharmacoepidemiol Drug Saf 2009, 18(9):807-814.
19. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007, 16(4):393-401.
20. McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr 2012, 12(1):78.
21. McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC. Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC Psychiatry 2012, 12(1):219.
22. Ruigomez A, Martin-Merino E, Rodriguez LA. Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf 2010, 19(6):579-585.
23. Sibbald B, Addington-Hall J, Brenneman D, Freeling P. Telephone versus postal surveys of general practitioners: methodological considerations. Br J Gen Pract 1994, 44(384):297-300.
24. Barkley RA, Murphy KR, Fischer M. ADHD in Adults: What the Science Says 2008, New York, NY: Guilford Press.
25. Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Dopfner M, Hamilton R, Hollis C, Holtmann M. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 2011, 20(1):17-37.
26. McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database. Drug Saf 2009, 32(11):1089-1096.
27. National Service Framework for Children, Young People and Maternity Services. Transition: Getting it Right for Young People. Improving the Transition of Young People with Long-Term Conditions from Children's to Adult Health Services. UK http://www.dh.gov.uk/assetRoot/04/13/21/49/04132149.pdf.
28. Asherson P, Chen W, Craddock B, Taylor E. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry 2007, 190:4-5.
29. ADHD - Services Over Scotland. Report of the Service Profiling Exercise http://www.healthcareimprovementscotland.org/programmes/mental_health/adhd/adhd_service_profile.aspx.
30. Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Dopfner M. Nonpharmacological interventions for adhd: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 2013, AiA:1-15.
31. Asherson P, Akehurst R, Kooij JJ, Huss M, Beusterien K, Sasane R, Gholizadeh S, Hodgkins P. Under diagnosis of adult ADHD: cultural influences and societal burden. J Atten Disord 2012, 16(5 Suppl):20S-38S.
32. Matheson L, Asherson P, Wong ICK, Clifford S. Adult ADHD Patients' Experiences of Impairment, Accessing Services and Treatment Management - A Qualitative Study in England 2012, 1. Prague, Czech Republic: European Psychiatry, 27, 20th European Congress of Psychiatry.
33. Service for the diagnosis and management of ADHD in adults. Commissioning and benchmarking tool. Implementing NICE guidance http://www.nice.org.uk/media/242/86/ADHDAdultsCommissioningGuide.pdf] [Accessed 21st June 2011.